India Needs to Increase the Pace of Research in Regenerative Medicine

India needs to increase the pace of research in regenerative medicine to come up to the global level, a doctor suggested.

Speaking at the International Conference on Regenerative Medicine and Stem Cells, a doctor said that India needs to increase the pace of research in regenerative medicine to come up to the global level, especially in the area of clinical trials and regulatory requirements.

"Autologous cell therapies with minimum manipulation also need standardization. A national level consortium should be formed consisting of governing authorities, academia, industry partners, researchers with the common goal of making mesenchymal stem cells available as Living Drugs to masses," said Dr. Pradeep Mahajan, Founder Chairman of StemRx, an organization in the field of regenerative medicine and cell based therapy.

Tissue Engineering and Regenerative Medicine
This new field is an amalgamation of biology, medicine and engineering, and is believed to have mind -boggling implications if fully potentialized.

‘One of the reasons India is unable to research more on regenerative medicine is the health and financial burden due to chronic debilitating diseases like diabetes and heart problems.’

Dr. Mahajan was invited to share his knowledge on Mesenchymal Stem Cells - the new drug on the horizon. During the conference he emphasized on how a single cell when applied properly can work as a multi-action drug.

According to Dr. Mahajan, one of the reasons India is unable to research more on regenerative medicine is the health burden due to chronic debilitating diseases like diabetes, heart problems, neurodegenerative disorders like Parkinson's and financial burden caused by it.

"With advent of cell based therapy and their availability such disease conditions can reduce these burdens to a great extent," said Mahajan.

Tighter Regulations on Innovative Surgical Practices in Regenerative Medicine
A new FDA draft guidelines would place even tighter restrictions on surgical practice and may limit the development of new therapies.

Source-IANS

Tissue Engineering, Regenerative Medicine Can Repair Lumbar Spinal Disc Herniation
Researchers described new therapeutic approaches to repair herniated discs in the lumbar spine using novel tissue engineering and regenerative medicine strategies.

Tissue Damage is a Major Factor for Cell Reprogramming
Tissue damage is a relevant factor for cells to go back to an embryonic state, revealed a new study.